Evidence map›Paper›PMID 34945850›Full record

ArticleJournal of personalized medicine2021

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (

Hee Young Cho, Han Sung Park, Eun Hee Ahn, Eun Ju Ko, Hyeon Woo Park, Young Ran Kim, Ji Hyang Kim, Woo Sik Lee, Nam Keun Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Evaluation ofCurrent protein & peptide science · 2026
    Article
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hee Young ChoDepartment of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul 06135, Korea.
Han Sung ParkDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.
Eun Hee AhnDepartment of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.
Eun Ju KoDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.
Hyeon Woo ParkDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.
Young Ran KimDepartment of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.
Ji Hyang KimDepartment of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Korea.ORCID 0000-0002-9864-9777
Woo Sik LeeFertility Center of CHA Gangnam Medical Center, CHA University, Seoul 06135, Korea.
Nam Keun KimDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.ORCID 0000-0003-0541-3528
CHA University · KRCHA University Bundang Medical Center · KR

Funding

Ministry of Health and Welfare HI18C19990200National Research Foundation of Korea 2020R1F1A107452511
6 · The paper itself

Abstract

Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses prior to 20 weeks of gestational age. Various factors, including immune dysfunction, endocrine disorders, coagulation abnormality, and genetic disorders influence RPL. In particular, plasminogen activator inhibitor-1 (

Indexed as

plasminogen activator inhibitor-1polymorphismrecurrent pregnancy lossrenintissue plasminogen activator

Identifiers

PMID34945850
PMCPMC8705673
OpenAlexW4200321043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.